Everolimus for severe arrhythmias in tuberous sclerosis complex related cardiac rhabdomyomas
- 16 February 2021
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (5) , 1525-1531
Abstract
Intracardiac rhabdomyoma is the most common primary cardiac tumor in children. Most cases are associated with tuberous sclerosis complex (TSC). Most of them are asymptomatic in the neonate and do not require treatment. However, some develop cardiovascular symptoms such as arrhythmias, heart failure, and ventricular inflow/outflow tract obstruction in the neonatal period with early death. Many of these tumors are not candidates for surgical resection and medical management is limited. Treatment with mammalian target of rapamycin (mTOR) inhibitor is currently approved for the management of central nervous tumors and angiomyolipoma in TSC. Two patients with malignant arrhythmias related to nonsurgical multiple rhabdomyomas associated with TSC who were successfully treated with an mTOR inhibitor were described. Everolimus therapy showed significant regression of rhabdomyomas with rapid improvement of arrhythmias and heart failure prior to tumor shrinkage.Keywords
This publication has 25 references indexed in Scilit:
- Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defectBMJ Case Reports, 2014
- Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmiaCardiology in the Young, 2014
- Regression of Symptomatic Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in a Newborn Receiving EverolimusJournal of Tropical Pediatrics, 2014
- Cardiac Rhabdomyoma in a Neonate With Supraventricular TachycardiaWorld Journal for Pediatric and Congenital Heart Surgery, 2014
- Is mTOR inhibition a systemic treatment for tuberous sclerosis?Italian Journal of Pediatrics, 2013
- Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in 11 Children: Presentation to OutcomePediatric Hematology and Oncology, 2012
- Everolimus: A Challenging Drug in the Treatment of Multifocal Inoperable Cardiac RhabdomyomaPediatrics, 2012
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous SclerosisNew England Journal of Medicine, 2010
- Recent advances in neurobiology of Tuberous Sclerosis ComplexBrain and Development, 2009
- Left ventricular outflow obstruction in rhabdomyoma of infancy: meta-analysis of the literatureThe Journal of Pediatrics, 2003